sv8
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
Registration Statement under the Securities Act of 1933
STERICYCLE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
36-3640402 |
(State or other jurisdiction
|
|
(I.R.S. Employer |
of incorporation or organization)
|
|
Identification Number) |
28161 North Keith Drive, Lake Forest, Illinois 60045
(Address of principal executive offices)
Stericycle, Inc. 2008 Incentive Stock Plan
(Full title of the plan)
Mark C. Miller
President and Chief Executive Officer
Stericycle, Inc.
28161 North Keith Drive, Lake Forest, Illinois 60045
(Name and address of agent for service)
(847) 367-5910
(Telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer o
|
|
Accelerated filer o
|
|
Non-accelerated filer o
|
|
Smaller reporting company o |
|
|
|
|
(Do not check if a smaller reporting company) |
|
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed |
|
|
Proposed |
|
|
|
|
|
Title of |
|
|
|
|
|
maximum |
|
|
maximum |
|
|
|
|
|
securities to be |
|
|
Amount to be |
|
|
offering price per |
|
|
aggregate offering |
|
|
Amount of |
|
|
registered |
|
|
registered(1) |
|
|
share(2) |
|
|
price(2) |
|
|
registration fee |
|
|
Common stock, par
value $.01 per
share |
|
|
3,500,000 shs. |
|
|
$59.49 |
|
|
$208,197,500.00 |
|
|
$8,182.85 |
|
|
(1) |
|
The aggregate number of shares to be registered is subject to adjustment by reason of stock
splits, stock dividends and other events pursuant to the anti-dilution provisions of the
Stericycle, Inc. 2008 Incentive Stock Plan. Accordingly, pursuant to Rule 416, this
registration statement covers, in addition to the number of shares of common stock shown in
the table above, an indeterminate number of shares of the registrants common stock that may
become issuable by reason of such provisions. |
|
(2) |
|
Computed pursuant to Rule 457(c), in accordance with Rule 457(h)(1), on the basis of the
average of the high and low reported sales price on August 4, 2008 of a share of the
registrants common stock on the NASDAQ Stock Market. |
TABLE OF CONTENTS
PART I
Information Required in the Section 10(a) Prospectus
Item 1. Plan Information
The information required by Item 1 is omitted from this registration statement in accordance
with the Note to Part I of Form S-8.
Item 2. Registrant Information and Employee Plan Annual Information
The information required by Item 2 is omitted from this Registration Statement in accordance
with the Note to Part I of Form S-8.
PART II
Information Required in the Registration Statement
Item 3. Incorporation of Documents by Reference
The registrant incorporates by reference in this registration statement the following
documents that the registrant has filed with the Securities and Exchange Commission (the
Commission):
(a) the registrants annual report on Form 10-K for the fiscal year ended December 31,
2007;
(b) the registrants quarterly reports on Form 10-Q for the quarters ended March 31 and
June 30, 2008;
(c) the registrants current reports on Form 8-K filed on February 6, February 22,
April 18, April 23 and July 24, 2008; and
(d) the description of the registrants common stock, par value $.01 per share,
contained in the registration statement on Form 8-A that the registrant filed on August 21,
1996, together with any amendment or report that the registrant may file for the purpose of
updating this description.
All documents that the registrant files with the Commission pursuant to Sections 13(a), 13(c),
14 or 15(d) of the Securities Exchange Act of 1934, as amended, after the filing of this
registration statement but prior to the filing of a post-effective amendment which (i) indicates
that all of the shares of the registrants common stock covered by this registration statement (the
shares) have been sold, or which (ii) deregisters all of the shares then remaining unsold, shall
be deemed to be incorporated by reference in and to be part of this registration statement from
their respective dates of filing.
Any statement in a document incorporated or deemed to be incorporated by reference in this
registration statement shall be deemed to be modified or superseded to the extent that a
statement in this registration statement, or in any document filed after the filing of this
registration statement which is deemed to be incorporated by reference in this registration
statement, modifies or supersedes the earlier statement. The earlier statement shall be deemed to
be incorporated in this registration statement only as so modified or superseded.
Item 4. Description of Securities
This item is not applicable.
Item 5. Interests of Named Experts and Counsel
The legality of the shares of the registrants common stock covered by this registration
statement is being passed upon for the registrant by Johnson and Colmar, 300 South Wacker Drive,
Suite 1000, Chicago, Illinois 60601, who serve as the registrants outside general counsel.
Partners of Johnson and Colmar beneficially own or have voting or investment power over 4,776
shares of the registrants common stock.
Item 6. Indemnification of Directors and Officers
Section 145 of the Delaware General Corporation Law provides generally that a person sued as a
director, officer, employee or agent of a corporation may be indemnified by the corporation in
non-derivative suits for expenses (including attorneys fees), judgments, fines, and amounts paid
in settlement if he or she acted in good faith and in a manner that he or she reasonably believed
to be in or not opposed to the corporations best interests. In the case of criminal actions and
proceedings, the person also must not have had reasonable cause to believe that his or her conduct
was unlawful. Indemnification of expenses is also authorized in stockholder derivative actions if
the person acted in good faith and in a manner that he or she reasonably believed to be in or not
opposed to the corporations best interests and if he or she has not been found liable to the
corporation. Even in this latter instance, the court may determine that, in view of all the
circumstances, the person is entitled to indemnification for such expenses as the court deems
proper. A person sued as a director, officer, employee or agent of a corporation who has been
successful in defense of the action must be indemnified by the corporation against expenses.
Article 5 of our amended and restated bylaws requires us to indemnify our directors, officers,
employees and agents to the maximum extent permitted by Delaware law. Article 5 also requires us to
advance the litigation expenses of a director or officer upon receipt of his or her written
undertaking to repay all amounts advanced if it is ultimately determined that he or she is not
entitled to indemnification. We have entered into individual indemnification agreements with each
of our directors and officers confirming and supplementing these rights to indemnification.
Section 102(b)(7) of the Delaware General Corporation Law permits a corporation to include a
provision in its certificate of incorporation eliminating or limiting the personal liability of a
director to the corporation or its stockholders for monetary damages for a breach of the directors
fiduciary duty of care. The provision may not eliminate or limit the liability of a director for
breaching his or her duty of loyalty, failing to act in good faith, engaging in intentional
misconduct or knowingly violating a law, declaring an illegal dividend or approving
2
an illegal stock repurchase, or obtaining an improper personal benefit. Article 10 of our
amended and restated certificate of incorporation eliminates the personal liability of our
directors to the fullest extent permitted by Section 102(b)(7).
If a director of ours were to breach his or her fiduciary duty of care, neither we nor our
stockholders could recover monetary damages from the director, and the only course of action
available to our stockholders would be equitable remedies, such as an action to enjoin or rescind
the transaction or event involving the breach of the fiduciary duty of care. To the extent that
claims against directors are thereby limited to equitable remedies, this provision of our amended
and restated certificate of incorporation may reduce the likelihood of derivative litigation
against our directors for breach of their fiduciary duty of care. In addition, equitable remedies
may not be effective in many situations. If a stockholders only remedy is to enjoin the completion
of the action in question by the board of directors, this remedy would be ineffective if the
stockholder does not become aware of the transaction or event until after its has been completed.
In this situation, the stockholder would not have an effective remedy against the directors.
By reason of directors and officers liability insurance that we maintain, our directors and
officers are insured against actual liabilities, including liabilities under the federal securities
laws, for acts or omissions related to the conduct of their duties.
Item 7. Exemption from Registration Claimed
This item is not applicable.
|
|
|
Item 8.
|
|
Exhibits |
|
4.1
|
|
Stericycle, Inc. 2008 Incentive Stock Plan |
|
5.1
|
|
Opinion of Johnson and Colmar |
|
23.1
|
|
Consent of Independent Registered Public Accounting Firm |
|
23.2
|
|
Consent of Johnson and Colmar (included in Exhibit 5.1) |
|
24.1
|
|
Power of attorney (included under the caption Power of Attorney on page 6) |
Item 9. Undertakings
Rule 415 Offering
The registrant undertakes:
(1) to file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act
of 1933, as amended (the Securities Act);
(ii) to reflect in the prospectus any facts or events arising after the effective
date of this registration statement (or the most recent post-effective amendment)
which, individually or in the aggregate, represent a fundamental change in the
3
information set forth in this registration statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered (if the total
dollar value of securities offered would not exceed that which was registered) and any
deviation from the low or high end of the estimated maximum offering range may be
reflected in the form of a prospectus filed with the Securities and Exchange
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than a 20 percent change in the maximum aggregate offering
price set forth in the Calculation of Registration Fee table in the effective
registration statement; and
(iii) to include any material information with respect to the plan of
distribution not previously disclosed in this registration statement or any material
change to such information in this registration statement;
provided, however, that undertakings (1)(i) and (1)(ii) shall not apply if the information
required to be included in a post-effective amendment by those undertakings is contained in
periodic reports filed with or furnished to the Commission by the registrant pursuant to
sections 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act)
that are incorporated by reference in this registration statement;
(2) that, for the purpose of determining any liability under the Securities Act, each
such post-effective amendment shall be deemed to be a new registration statement relating to
the securities offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof; and
(3) to remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering; and
Filings Incorporating Subsequent Exchange Act Documents by Reference
The registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the registrants annual report pursuant to sections 13(a) or 15(d)
of the Exchange Act which is incorporated by reference in this registration statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
Commission Position on Indemnification
Insofar as indemnification for liabilities arising under the Securities Act may be permitted
to directors, officers and controlling persons of the registrant pursuant to the Delaware General
Corporation Law or the registrants certificate of incorporation and bylaws or individual
indemnification agreements, as described in Item 6, or otherwise, the registrant has been advised
that in the opinion of the Commission such indemnification is against public policy as expressed in
the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by
a director, officer or controlling person of the registrant in the successful
4
defense of any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a
court of appropriate jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final adjudication of such
issue.
5
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Lake Forest, State of Illinois, on August 8, 2008.
|
|
|
|
|
|
Stericycle, Inc.
|
|
|
By |
/s/ Mark C. Miller
|
|
|
|
Mark C. Miller |
|
|
|
President and Chief Executive Officer |
|
Power of Attorney
Each person whose signature appears below who is then an officer or director of the registrant
authorizes Mark C. Miller, Richard T. Kogler and Frank J.M. ten Brink, or any one of them, with
full power of substitution and resubstitution, to sign in his name and to file any amendments
(including post-effective amendments) to this registration statement and all related documents
necessary or advisable to enable the registrant to comply with the Securities Act of 1933, as
amended, in connection with the registration of the securities which are the subject of this
registration statement, which amendments may make such changes in this registration statement (as
it may be so amended) as Mark C. Miller, Richard T. Kogler and Frank J.M. ten Brink, or any one of
them, may deem appropriate, and to do and perform all other related acts and things necessary to be
done.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed below by the following persons in the capacities and on the dates indicated.
|
|
|
|
|
Name |
|
Title |
|
Date |
|
|
|
|
|
/s/ Jack W. Schuler
Jack W. Schuler
|
|
Chairman of the
Board of Directors
|
|
August 8, 2008 |
|
|
|
|
|
/s/ Mark C. Miller
Mark C. Miller
|
|
President, Chief
Executive Officer
and a Director
(Principal
Executive Officer)
|
|
August 8, 2008 |
|
|
|
|
|
/s/ Frank J.M. ten Brink
Frank J.M. ten Brink
|
|
Chief Financial
Officer (Principal
Finance and
Accounting Officer)
|
|
August 8, 2008 |
|
|
|
|
|
/s/ Thomas D. Brown
Thomas D. Brown
|
|
Director
|
|
August 8, 2008 |
|
|
|
|
|
/s/ Rod F. Dammeyer
Rod F. Dammeyer
|
|
Director
|
|
August 8, 2008 |
6
|
|
|
|
|
Name |
|
Title |
|
Date |
|
|
|
|
|
/s/ William K. Hall
Patrick F. Graham
|
|
Director
|
|
August 8, 2008 |
|
|
|
|
|
/s/ Jonathan T. Lord, M.D.
Jonathan T. Lord, M.D.
|
|
Director
|
|
August 8, 2008 |
|
|
|
|
|
/s/ John Patience
John Patience
|
|
Director
|
|
August 8, 2008 |
|
|
|
|
|
/s/ Thomas R. Reusché
Thomas R. Reusché
|
|
Director
|
|
August 8, 2008 |
|
|
|
|
|
/s/ Ronald G. Spaeth
Ronald G. Spaeth
|
|
Director
|
|
August 8, 2008 |
|
|
|
|
|
/s/ L. John Wilkerson, Ph.D.
L. John Wilkerson, Ph.D.
|
|
Director
|
|
August 8, 2008 |
7